| Market Cap | ₹805Cr |
| ROE | 11.84% |
| P/E Ratio(TTM) | 20.81 |
| EPS(TTM) | 3.86 |
| P/B Ratio | 2.46 |
| Dividend Yield | 0.93% |
| Industry P/E | 39.95 |
| Book Value | 32.62 |
| Debt to Equity | 0.00 |
| Face Value | 5 |
| Parent Organisation | Anuh Pharma |
| Managing Director | Mr. Ritesh B. Shah |
| Founded | 1960 |
| NSE Symbol | ANUHPHR |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 68.62 | ||
| Neuland Laboratories | NA (0.00%) | 79.94 | ||
| Jubilant Pharmova | NA (0.00%) | 36.07 | ||
| Acutaas Chemicals | NA (0.00%) | 59.91 |